COLL vs TMO · P/E 17, rev $181.9M vs P/E 24, rev $44.56B
Collegium Pharmaceutical Inc (COLL) versus Thermo Fisher Scientific Inc (TMO) — a side-by-side from cached financials, not a winner call.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Thermo Fisher Scientific Inc (TMO) is a diagnostics & research company listed on US.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
Latest reported TMO revenue for 2025-12-31 was $44.56B. Net income was $6.70B. Revenue was up 3.9% from 2024-12-31 to 2025-12-31. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
COLL currently screens at market cap $1.12B and trailing P/E 16.8. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
Not investment advice. Open the COLL and TMO stock pages for the full models.
Not investment advice.